The effect of mast cell stabilizers on non-alcoholic fatty liver

Phase 2

• Conditions: on-alcoholic fatty liver disease.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20220104053626N6
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age 18 to 59 years
Willingness to participate in the study
No history of alcohol consumption
Do not take drugs with liver toxicity

Exclusion Criteria

Having liver disease with specific etiologies such as viral hepatitis
Alcohol consumption
Pregnancy and lactation
Take other drugs anti histamine or anti cholinergic
Cirrhosis of the liver
Uncontrolled diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hepatic steatosis elastographic index in patients with non-alcoholic fatty liver disease. Timepoint: Before and after the intervention. Method of measurement: CAP index in liver elastography.;Hepatic fibrosis elastographic index in patients with non-alcoholic fatty liver disease. Timepoint: Before and after the intervention. Method of measurement: LSM index in liver elastography.